Search Results for 'bone therapeutics'
-
Biologics
Bone Therapeutics Appoints New Chairman
Jean Stéphenne brings extensive biotech and pharma experience to the the bone cell therapy company.GlobeNewswire 02.21.18
-
Bone Therapeutics Appoints Chief Financial Officer
New hire has extensive international finance experience at major public and privately-owned companies.Bone Therapeutics 09.01.17
-
Biologics
Bone Therapeutics Completes Recruitment in Spinal Fusion Study
Company is also extending trial to assess early onset of bone formation and fusion.Bone Therapeutics SA 05.03.16
-
Biologics
Bone Therapeutics Bullish on Primary Trial Results of Cell-Based, Bone-Forming Product
Trial is evaluating safety and efficacy of Allob product to treat delayed-union fractures of long bones.01.21.15
-
Bone Therapeutics Authorized to Enroll Patients in U.K. Clinical Trial
Five British centers approved to test regenerative therapy.12.09.14
-
Bone Therapeutics and Kasios Form Product Development Partnership
Bone Therapeutics also appoints chief clinical/regulatory officer.11.24.14
-
Bone Therapeutics and Kasios Collaborate on Spinal Fusion Product
Joint effort to combine Bone Therapeutics' cell therapy product with synthetic bone substitute.11.17.14
-
Research & Development
Bone Therapeutics Awarded $5.2 Million Research Grant
Company tapped to help develop technology platform of bio-mimetic and bioactive materials.02.20.14
-
Bone Therapeutics Receives Clearance for Allob Phase I/IIa Trial
Product designed to treat delayed union fractures.10.17.13
-
Bone Therapeutics Hires CFO
New executive has more than 25 years of international business experience.10.10.13
